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Epstein-Barr virus (EBV) confers upon normal lymphocytes derived from bone marrow the
ability to proliferate indefinitely in a test tube. This process, called immortalization, is crucial
to the pathogenesis of EBV infections. Inside the immortalized lymphocyte the EBV genome
exists as a complete multicopy circular plasmid which is probably not integrated into the cell
chromosome. Most of the viral genetic information is not expressed. However, at least six to
eight separate regions ofthe EBV genome encode viral products which are made in the immor-
talized cell. The identification of the function of these few genes holds some interesting
answers to questions concerning the biochemical mechanisms ofcontrol oflymphocyte growth
and differentiation.
A crucial point of interaction between a parasite and its host underlies the
pathogenesis of most infectious diseases. This interface is often called a site of
"tropism," a place on or in a specialized target cell where effects occur which are
responsible for the pathologic and ultimately the clinical signs of the disease. Ex-
amples come readily to mind. There are respiratory viruses with characteristic affin-
ity for upper airways (common cold viruses), middle airway (croup associated
viruses), and lower airways (respiratory syncytial virus). Although they initiate in-
fection in the gut, and traverse the blood, polioviruses ultimately home to anterior
horn cells of spinal cord [1]. Rabies virus travels to the temporal lobe via peripheral
nerves. Although some other viruses are not nearly so finicky in their preferences,
even those which affect many tissues, measles, for example, can be tracked to a
favorite haunt, such as a small patch of buccal mucosa near the parotid salivary
gland duct.
Virologists seldom enjoy the opportunity to study these fine-tuned viral adapta-
tions to specialized target cells. Until recently it has been difficult to grow well-
differentiated cells in tissue culture so that they retain their unique characteristics.
We have a vague feeling that many ofthese tropisms are due to receptors on the out-
side of cells for specialized portions on the outside of viruses, but we do not know
much about intracellular events which govern the interactions of viruses within
specialized cells. However, in at least one instance we can now regularly put a dif-
ferentiated cell in culture and study intracellular events which underlie the
pathogenesis of an infection.
In the 1960s techniques of tissue culture had advanced to the point where it
became possible to grow continuous cultures of certain types of human lymphoid
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All rights of reproduction in any form reserved.cells [2]. Often these cell lines were derived from patients with various leukemias and
lymphomas, but occasionallythey were established from normal individuals or from
patients with diverse diseases. In the mid-1960s it was found that some, but not all, of
these lymphoid cell lines contained a new human herpes virus, Epstein-Barr virus
(EBV), which was first seen in alymphoid line from a Burkitt lymphoma [3]. Could
this new virus be responsible for the continuous growth of lymphoid cell lines?
The first experiment which suggested that this might be the case was reported in
1967 by the Henles and their associates [4]. They lethally X-irradiated an EBV car-
rier Burkitt lymphoma line derived from an African boy called Jijoye, and co-
cultivated the X-irradiated cells with leukocytes from a female infant. After a
number of weeks a lymphoid line was established which had a female karyotype.
Although the infant's cells before co-cultivation contained no identifiable viral an-
tigens, the established line contained an antigen which was also found in the Burkitt
lymphoma cells. This type of experiment was carried out in other laboratories at
about the same time, using X-irradiated EBV carrier cells established from patients
with leukemia. Subsequently it was shown that partially purified EBV rather than
cell-associated virus was capable of inducing the continuous growth of the lym-
phocytes [5]. The proof that EBV was responsible was based ultimately on the
demonstration that growth ofthe normal cells could be inhibited ifantibody to EBV
was included in the system [6].
TRANSFORMATION VERSUS IMMORTALIZATION
Since EBV was found first in lymphoma cells, the question naturally arose
whether acquisition of the ability to grow continuously in a test tube was tanta-
mount to a change from a normal cell to a cancer cell. This question has not been
easy to answer. Most ofthe evidence suggests that, while enhanced in vitro growth is
often a property of a cancer cell, it is not the whole story. Thus soon after the
phenomenon was put on a firm experimental basis, there arose the important ques-
tion of what to call it. The word transformation is generally used to describe such
events, but transformation also describes many unrelated phenomena including the
uptake ofDNA andexpression of new information bybacteria(Avery's transforma-
tion), the response oflymphocytes to mitogenic stimuli, such as phytohemagglutina-
tion, and oncogenic transformation by tumor viruses. Since the question of
tumorigenicity of the growing lymphocytes was unresolved, I tried to find another
name, and hit on immortalization [7]. This term has drawn criticism as being
presumptuous, for we shall never know whether alymphocyte is immortal, but it has
withstood the test of usage. In fact, as we become more aware of the sequence of
changes which accompany the conversion from normal to malignant, its usage has
increased.
TARGET CELLS
All lymphocytes which have been immortalized in vitroby EBV show attributes of
B cells; usually they synthesize immunoglobulin. It is still unknown whether im-
mature B-cell precursors can be immortalized. The most susceptible cell in
laboratory studies seems to be a resting, well-differentiated, B cell [8].
This matter oftarget cell is ofmore than theoretic interest; the nature ofthe target
cell is likely to influence the features of the disease. If it could be shown that EBV
immortalizes a stem cell and there were unambiguous ways to identify such cells,
then it might be possible to learn whether some B-cell malignancies associated with
EBV were due to immortalization of B stern cells, an unusual target.
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The target cell ultimately influences the expression of the EBV which immortal-
ized it. All lymphocytes tend to inhibit the expression of EBV, but some more than
others. If the lymphocytes come from umbilical cord blood, they tightly restrict
EBV expression; from adult blood they are more relaxed; the lymphocytes of some
New World primates permit considerable expression of EBV in the transformed
cells, thus providing a source of virus for laboratory study [9].
These host restrictions on EBV expression in the immortalized cell may also in-
fluence the pathogenesis of the EBV-associated diseases. Clinical expression ofEBV
infection in the young child is generally less intense than in the older child. Since we
know now that the pathogenic features of mononucleosis are principally due to the
immune response, it is not too great a leap to posit that the subdued immune
response in the young child is somehow related to the muted behavior ofthe virus in
young cells.
EVENTS LEADING TO IMMORTALIZATION
It is possible to study the events leading to immortalization in cell culture.
Therefore it should eventually be possible to recreate the cellular and molecular
pathogenesis of the single most important aspect of EBV infections. These events
are now discerned only in rough outline. There is attachment to a receptor on the B
cell, thought to be the receptor for C3 or something closely linked to it. Adsorption
and penetration are quickly accomplished, but the details ofhow the virus enters are
not known. The first recognizable event, after six to eight hours, is the synthesis of a
nuclear neo-antigen called EBNA; about 20 hours after infection, cellular DNA syn-
thesis is stimulated and about 16 hours later the first EBNA-positive cells are seen to
enter mitosis [10]. There may be some further events which are needed to solidify the
immortalization reaction, which does not begin in earnest until about five days after
infection, when cell numbers begin to increase.
At some point during immortalization the EBV genome reproduces itself, not
massively up to several thousand copies per cell as occurs in a productive viral infec-
tion, but cautiously and conservatively-usually somewhere between five and 50
copies per cell. After immortalization, this copy number is usually fairly constant
[11]. "Genome amplification" is a regular occurrence and one cannot help feeling it
is in some way tied in a causative way to immortalization.
IMMORTALIZED CELLS CONTAIN A LARGE PORTION
OF EBV DNA OR ALL OF IT
The EBV genome probably contains at least 50 to 100 genes, based on its size
alone. Most of these genes are likely to function in the replication of mature virus
and, as such, are probably not involved in the immortalization process. Yet the im-
mortalized cell invariably contains a nearly complete copy of the genome. Since no
virions are being made in the majority of cells, most of the genes must be shut off.
Nonetheless the whole viral DNA is present if one looks for it by biochemical means
(Southern blotting) or by biologic tests. It is possible to recover infectious virus from
immortal B cells by X-irradiating them and co-cultivating them with fresh lym-
phocytes [9].
Thus, lymphocytes immortalized by EBV are excellent cells in which to analyze
the biochemical basis of viral latency. They contain a masked viral genome which is
periodically spontaneously activated in some cells and which can be induced to
replicate by certain chemical and physical stimuli.
It takes energy to conserve many copies of this large viral genome in a lym-
307phocyte. There must be a reason for maintaining this entire genome, even though
new virus is not made. Several explanations have some basis in experimental obser-
vation. Inside the cell the genome is circular; in the virion the genome is linear [12].
Circularization probably requires repeated sequences at the ends of the molecule. If
the molecule is interrupted circularization may not occur, unless the ends are
preserved. Inside the immortalized cell the genome is amplified; this may take place
as the result of viral enzymes involved in DNA synthesis. In fact, the synchronous
replication of the Epstein-Barr viral plasmid with its host cell and its partition to
daughter cells may be under the control of viral genes.
Although many viral genes are shut off in the immortalized cells, a considerable
number of areas of the genome are expressed as RNAs. There are at least six to eight
transcribed regions scattered over the genome [13]. This may be the real reason why
we see the whole viral genome in the cells. We know little of the business of these ac-
tive regions; one region encodes two small RNAs which do not function as
messenger RNAs, but become complexed with protein and serve some as yet uniden-
tified function [14]. Another transcribed region encodes the Epstein-Barr nuclear
antigen, as yet still mysterious in terms of structure or function.
HOW MIGHT THE IMMORTALIZING GENES WORK?
We are beginning to know something about how RNA tumor viruses transform
cells or cause tumors, but the mechanism of action of the transforming genes of
DNA tumor viruses is still mysterious. The two major pathways to tumorigenesis by
retroviruses are to code for new proteins which are protein kinases or to integrate
into cellular DNA and to cause cellular genes to be expressed because of promoters
or because of gene rearrangements [15]. The product of these cellular genes may also
function as protein kinases.
It is perhaps a naive way of looking at it, but since EBV is a large complex virus, it
seems likely that the immortalization reaction too is going to be complex. Perhaps
those biologists are wise who study the simplest systems. At any rate, since many
viral genes are expressed in immortalized cells, I would predict that the products of
these genes interact in some way to produce a cascade of effects. Probably most of
these genes function primarily to maintain the vegetative state of the viral genome;
that is, they serve to replicate and conserve the copy number. Perhaps the immor-
talization reaction is entirely a by-product of the viral genome's efforts to preserve
itself. On the other hand, the virus may need to immortalize the cell first in order for
the cell to supply some essential function which the virus requires and which cannot
be found in a resting lymphocyte.
One attractive hypothesis is that the virus either encodes or induces a "hormone"
or a receptor for a hormone in the culture medium. This hormone may be a
perpetual mitogen.
The immortalization reaction is well on its way within 20 hours after infection
when the cell is pushed into DNA synthesis. This is fast transformation and
bespeaks the existence of viral gene products which act directly, rather than by some
indirect mechanism such as integration and promotion of expression of cellular
genes. In fact, there is little evidence that EBV integrates into cellular DNA.
The truth is we do not really know how this process might work. We badly need
mutants which are deficient in immortalization. Only one such mutant exists, prob-
ably as the result of an event which occurred by chance while the virus was being
propagated in the laboratory. We know now that, by comparison with its parent,
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this mutant has a single deleted segment of viral DNA [16]. No doubt this missing
piece of DNA performs a function which is essential in initiating immortalization.
Aided by the powerful new methods of recombinant DNA and gene transfer, we
should be able to learn what these missing genes do.
IMMORTALIZATION IS NOT NECESSARILY ONCOGENESIS
A cell immortalized in a test tube or in a patient does not often become a cancer,
though it has the potential for becoming a malignant cell. Some nonhuman primates
and certain immunodeficient patients lack one or more components of the immune
system which are involved in detecting and eliminating immortalized cells. This is an
example of a host-determined susceptibility to malignancy.
The lymphomas which are the result ofthe unbridled growth ofimmortalized cells
in immunocompromised hosts are polyclonal; they derive from proliferation of a
number of different cell clones which have probably received the virus in separate
events [17]. Some would prefer not to call these true neoplasms, but these seem to
me to be semantic distinctions. The immortalized cell in an immunodeficient host
shows all the antisocial properties which are attributes of cancer cells-unlimited
growth and invasion of normal boundaries between tissues and organs.
Unanswered is the question whether immortalization by EBV can also set the
stage for the type of malignancy which occurs in immunologically normal persons.
In the case of Burkitt lymphoma, it is likely that there are events which occur subse-
quent to immortalization. These probably include the chromosome abnormalities
which arecharacteristic ofthe disease, and may well involve other somatic cell muta-
tions which we can not yet identify. The idea of tumor progression has been on the
minds ofbiologists who study cancer at least since Peyton Rous. Even after we have
a clearer idea of what viral genes lead to immortalization, we shall be left with ques-
tions about the progression to malignancy. Does the virus participate in this process,
too, in a direct way? By providing a perpetual stimulus to growth does it permit
events to occur, such as mutations, gene rearrangements, or changes in the control of
the expression of genes, which overcome the ability of the cell to police its own
genetic stability?
Such is the nature of scientific problem-solving. Just as one set of questions has
been posed, and some partial solutions encountered by experiment, new questions
immediately reveal themselves. The study of lymphocyte immortalization should
provide several generations thejoy ofthis struggle. Such study has already had some
useful by-products, among them a regular method to establish human cell banks for
laboratory study of genetic disease and normal physiologic processes, and the
possibility of making human monoclonal antibody from immortalized cells. No
doubt further analysis of the intracellular pathogenesis of EBV infections will con-
tinue to offer up surprises and an occasional finding which is beneficial to human
welfare.
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